APA

Fox S. H., Henry B., Hill M. P., Peggs D., Crossman A. R. & Brotchie J. M. (20011018). Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan. : Movement disorders : official journal of the Movement Disorder Society.

Chicago

Fox S H, Henry B, Hill M P, Peggs D, Crossman A R and Brotchie J M. 20011018. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan. : Movement disorders : official journal of the Movement Disorder Society.

Harvard

Fox S. H., Henry B., Hill M. P., Peggs D., Crossman A. R. and Brotchie J. M. (20011018). Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan. : Movement disorders : official journal of the Movement Disorder Society.

MLA

Fox S H, Henry B, Hill M P, Peggs D, Crossman A R and Brotchie J M. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan. : Movement disorders : official journal of the Movement Disorder Society. 20011018.